GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (OTCPK:MDXHF) » Definitions » 3-Year EBITDA Growth Rate

MDXHF (Medx Health) 3-Year EBITDA Growth Rate : 12.60% (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medx Health 3-Year EBITDA Growth Rate?

Medx Health's EBITDA per Share for the three months ended in Sep. 2024 was $-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 12.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Medx Health was 54.10% per year. The lowest was -86.90% per year. And the median was 1.50% per year.

Competitive Comparison of Medx Health's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Medx Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medx Health's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Medx Health's 3-Year EBITDA Growth Rate falls into.


;
;

Medx Health 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Medx Health  (OTCPK:MDXHF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Medx Health 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Medx Health's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medx Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (OTCPK:MDXHF) » Definitions » 3-Year EBITDA Growth Rate
Comparable Companies
TSXV:THRM TSXV:CNVI TSXV:FREQ TSXV:ASG TSXV:VPT TSXV:ZCT TSXV:NGMD TSXV:EVMT XCNQ:PMED XCNQ:MYTC ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
MDX:Canada
Address
1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2
Website
https://www.medxhealth.com
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.